论文部分内容阅读
随着念珠菌感染，尤其是免疫功能受损和AIDS患者深部感染的急剧增多，念珠菌对隆类药物的耐药日益严重[1]。因此很有必要建立一种确实可行的真菌药过方法以指导临床。有关真菌药敏的研究已取得较大进展，其中RPMI1640液基稀释法已被美国国家临床试验标准化委员会（NCCLS）作为
With Candida infection, especially impaired immune function and the deep infection of AIDS patients increased sharply, Candida albifroides drug resistance is increasingly serious [1]. Therefore, it is necessary to establish a viable method of fungal medicine to guide the clinical. Great progress has been made in the research on fungal susceptibility. Among them, the liquid-based dilution method of RPMI1640 has been adopted by the National Committee for Clinical Trials Standards (NCCLS)